Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Return to: PBR Home | Drug Research
Today in Drug Research

Drug Research

AstraZeneca, Pieris form $2.1bn respiratory drug collaboration AstraZeneca will develop new inhaled respiratory treatments based on Pieris Pharmaceuticals’ Anticalin platform through a collaboration that could generate more than $2bn for the US firm. Drug Research > Drug Discovery & Development > News

Latest Drug Research News by Sector

Select a sector from the list or browse by sector below:

Drug Delivery

EC launches probe into Aspen's pricing practices for cancer drugs
The European Commission has initiated a formal investigation to see whether Aspen Pharma had excessively priced five life-saving cancer medicines.
Regulatory Affairs > News
Clinigen, Tesaro partner to supply ovarian cancer drug in Europe
Clinigen Group’s Idis Managed Access division and Tesaro have partnered to launch a Managed Access Program (also known as an Early Access Program) in Europe for niraparib, the investigational PARP 1/2 inhibitor, for patients with recurrent ovarian cancer.
Drug Research > Drug Delivery > News

Drug Discovery & Development

Merck licenses Teijin Pharma's Alzheimer's candidate
Merck has signed a worldwide license agreement with Teijin Pharma for the development, manufacture and commercialization of an investigational preclinical antibody candidate targeting the protein tau.
Drug Research > Drug Discovery & Development > News
Harpoon Therapeutics raises $45m in new funding round
Harpoon Therapeutics has secured $45m in Series B financing, which included new investors Arix Bioscience, New Leaf Venture Partners and Taiho Ventures along with existing investor MPM Capital.
Drug Research > Drug Discovery & Development > News